We describe a sensitive and precise gas-chromatographic method in which benzylmalonate methylester monoamide is used as the internal standard for the simultaneous determination of primidone, phenylethylmalonamide, carbamazepine, and diphenyihydantoin. The trimethylsilyl derivatives of the anticonvulsants are well separated from each other and from normal serum constituents. The lower limit of detection for each drug is 0.5 mg/liter when 1 ml of serum is analyzed. Withinrun precision (CV), established by analysis of 10 replicates, was as follows: primidone (5.4 mg/liter), 2.6%; phenylethylmalonamide (5.5 mg/liter), 1.6%; diphenylhydantoin (6.6 mg/liter), 3.8%; and carbamazepine (10.4 mg/liter), 3.2%. Fifty specimens were analyzed for primidone and 35 for diphenylhydantoin by a standard gas-chromatographic method involving on-column methylation and by the procedure we have developed. The mean value observed for primidone with the on-column alkylation procedure was 9.3 mg/liter and with our procedure was 9.6 mg/liter. When values for our assay were regressed against values for the standard method, the slope of the least-squares line was 0.936, the intercept was 1.00 mg/liter, and r was 0.939. The mean values observed for diphenylhydantoin by on-column methylation and with our procedure were both 12.6 mg/liter. When values for our assay were regressed against the standard method, the slope of the leastsquares line was 0.944, the intercept was 0.3 mg/liter, and rwas 0.988. 
a drug utilized widely in the management of seizures, is partially metabolized to phenobarbital and phenylethylmalonamide. Because both primidone and phenobarbital possess anticonvulsant activity (1) , it is desirable to measure the concentrations of both compounds in serum after therapy with primidone.
It remains to be determined to what extent phenylethylmalonamide contributes to the anticonvulsant activity of primidone in man. Baumel et al. (1) first described a gas-chromatographic procedure for determining primidone and phenylethylmalonamide as their trimethylsilyl derivatives. However, they did not use an internal standard in their assay, and they estimated the amounts of these drugs by measuring absolute peak heights.
Moreover, single chloroform extractions of plasma were used, which also extract extraneous substances that interfere with gas-chromatographic measurement of the compounds of interest. Subsequently, these investigators utilized 5-(p-methylphenyl)-5-phenylhydantoin (MPPH)1 as an internal standard, and reported the day-to-day variation in the slope of the standard curve as <5% (2).
Kananen et al. 
Materials and Methods

Reagents and Comparison Materials
Instrumentation and Instrumental Conditions
We used a Hewlett Packard 5710A Gas Chromatograph equipped with dual flame-ionization detectors and a 1-mV Model 7123A recorder.
The glass columns were 122 cm X 2 mm i.d., configuration 5 for on-column injection (Hewlett Packard), packed with 3% OV-17 on 100/120 Gas Chrom Q (Applied Science Lab.). Septa were type HT-9 (Applied Science Lab.) high temperature, low bleed. The instrumental conditions were: Injector port temperature, 250 #{176}C; detector temperature, 300 #{176}C; oven temperature, programmed 150-260 #{176}C at 16 #{176}C/min; gas flow rates: nitrogen, 40 ml/min, air, 250 ml/min, and hydrogen 40 mi/mm; and recorder chart speed, 13 mm/mm.
Syntheses
Benzylmalonate met hylester monoamide. This was synthesized according to the procedure of Russell (9) for preparation of monosubstituted malondiamides.
Diethyl benzylmalonate (10 g) was dissolved in anhydrous methanol (100 ml) containing sodium methylate (233 mg). The solution was cooled to 0 #{176}C and gaseous ammonia was bubbled through it for 10 mm. The mixture was kept in a stoppered flask at room temperature for 6 h, then the solvent was removed under reduced pressure. The product, methyl benzylmalonate monoamide, was recrystallized twice from methanol by gradual addition of water until crystallization commenced. The yield from this synthesis averaged 85% (for four such preparations).
The course of the reaction was monitored by periodic gas-chro- 9). Conditions were the same as described above except for the reaction time, which was 24 h at 25 #{176}C.
Procedure for Extraction and
Silylation of Anticonvulsants Serum, 1 ml, was combined in a 16 X 125 mm test tube (Teflon-lined screw cap) with 1 ml of phosphate buffer (1 mol/liter, pH 6.8) and 10 ml of dichloromethane containing 15 tg of the internal standard, BMMA.
The tubes were shaken for 10 mm in an Eberbach shaker at 250 oscillations/mm and centrifuged at 1500 rpm for 3 mm. The aqueous (upper) phase was aspirated and discarded. The dichloromethane was transferred to fresh 16 X 125 mm test tubes and evaporated under a stream of nitrogen in a water bath at 40 #{176}C. Methanol, 1 ml, was added and the tubes were held in an ultrasonic bath for 10 s, to ensure solution of the residue. Four milliliters of HC1 (0.5 mol/liter) was added and the contents of the tubes were mixed on a vortex-type mixer for 5 s. Hexane, 7 ml, was added and the tubes were shaken for 10 mm in the Eberbach shaker as described above and centrifuged for 5 mm at 2000 rpm. The hexane (upper) layer was aspirated and discarded and the aqueous layer was washed again with 7 ml of hexane.
Dichloromethane, carded. Anhydrous Na2SO4 (0.5 g) was added to each sample, and the contents of the tube were mixed well and then centrifuged for 2 mm at 2000 rpm. The dichioromethane was transferred into 7-ml screw-cap septum vials and evaporated under a stream of nitrogen in a 40 #{176}C water bath. Regis silylation mix (50 gil) was added to each residue, and each vial was capped immediately thereafter.
The vials were mixed on a vortex-type mixer, allowed to stand for 30 mm at room temperature, then 1 l of sample was injected into the gas chromatograph.
Results were calculated by the peak-height ratio method, with BMMA as the internal standard.
Standard curves were prepared by analyzing samples of normal human serum containing known amounts of each drug. These serum-based standards were prepared by evaporating under nitrogen appropriate amounts of alcoholic solutions of the anticonvulsants and adding 1 ml of normal serum.
Analysis of diphenylhydantomn and primidone for purposes of correlation with our method were performed by on-column methylation by the method of 
Results
Benzylmalonamide, phenethylmalonamide, phenylmalonamide, and benzylmalonate methylester monoamide were evaluated as possible internal standards in this procedure.
The first three compounds were poorly extracted and their tnimethylsilyl derivatives did not separate well from chromatographic peaks representing normal constituents in serum. In contrast, benzylmalonate methylester monoamide was well extracted from serum and its trimethylsilyl derivative was well separated from the normal constituents in serum and the anticonvulsant drugs of interest.
Representative chromatograms of serum specimens extracted and silylated according to our procedure are presented in Figure 1 . The sensitivity of the method was such that pnimidone, PEMA, diphenylhydantoin and carbamazepine could be readily quantitated at a concentration of 0.5 mg/liter when the sample volume was 1.0 ml. Table 1 presents precision data for the drugs analyzed by our procedure. Within-run precision was estimated both by analysis of 10 replicate samples and from paired duplicates.
Overall precision was estimated from data obtained on samples analyzed over 6 months. Figure 2 illustrates typical standard curves from pnimidone, PEMA, diphenylhydantoin and carbamazepine prepared by the peak height ratio technique utilizing BMMA as the internal standard.
Recoveries of the drugs from serum were measured in the following way: 15 tg of each compound, in methanol, was evaporated and to the residue was added 1 ml of drug-free serum. This sample was extracted as described in the Methods section; however, volume transfers were quantitated. A second (non-extracted) standard was prepared concurrently by evaporating 15 iig of the same compounds to dryness, and both sample and standard were derivatized by addition of 50 l of silylating reagent. One microliter of each sample was chromatographed.
The peak heights of the serum sample were corrected for solvent transfers. Absolute recoveries of the drugs from serum were calculated by comparison of the ratio of 
Discussion
Determinations of primidone are described that involve extraction of the drug and subsequent gaschromatographic analysis as either methylated or silylated derivatives.
The results presented here demonstrate a good correlation (r = 0.939) between our method for primidone and one involving on-column methylation.
The improved precision we attained is due in part to the better extraction efficiency (42%) attained in our method.
Baumel et al.
(1) did not present information on the reproducibility of their procedure, but it is likely that precision was limited by the injection technique, because no internal standard was included in their assay. Our method for determination of phenylethyl-. malonamide as its tnimethylsilyl derivative gave a CV of 1.6% at a concentration of 5.5 mg/liter. This excellent reproducibility is related primarily to use of BMMA, a compound related in structure to phenylethylmalonamide, as an internal standard. The method we used for extraction of phenylethylmalonamide from serum was that used by Roger et al. (6) for the determination of carbamazepine and other anticonvulsants, including primidone, in human plasma. Extraction efficiency of phenylethylmalonamide with this procedure was 47%. Kupferberg (7) described a method for determination of carbamazepine as the trimethylsilyl derivative in which was used an extraction procedure closely related to that reported by Roger et al. (6). Recovery of carbamazepine by both extraction procedures was in excess of 90%. Kupferberg (7) included the chromatogram of a plasma extract from a patient receiving carbamazepine and primidone, and it is interesting to note a relatively large unidentified peak with a retention time of approximately 6 mm. The position of this peak relative to that of primidone makes it likely that it represents the trimethylsilyl derivative of phenylethylmalonamide.
Patients with severe seizure disorders are fre-
